In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges

被引：175

作者：

Mout, Rubul ^{[1
]}

Ray, Moumita ^{[1
]}

Lee, Yi-Wei ^{[1
]}

Scaletti, Federica ^{[1
]}

Rotello, Vincent M. ^{[1
]}

机构：

[1] Univ Massachusetts, Dept Chem, 710 North Pleasant St, Amherst, MA 01003 USA

来源：

BIOCONJUGATE CHEMISTRY | 2017年 / 28卷 / 04期

关键词：

MUSCULAR-DYSTROPHY; MEDIATED DELIVERY; MOUSE MODEL; HUMAN-CELLS; GENOME; CAS9; RNA; CRISPR-CAS9; NUCLEASES; ENDONUCLEASE;

D O I：

10.1021/acs.bioconjchem.7b00057

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

The successful use of clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9-based gene editing for therapeutics requires efficient in vivo delivery of the CRISPR components. There are, however, major challenges on the delivery front. In this Topical Review, we will highlight recent developments in CRISPR delivery, and we will present hurdles that still need to be overcome to achieve effective in vivo editing.

引用

页码：880 / 884

页数：5

共 50 条

[1] Delivery of CRISPR/Cas9 for therapeutic genome editing
Xu, Xiaojie
Wan, Tao
Xin, Huhu
Li, Da
Pan, Hongming
Wu, Jun
Ping, Yuan
JOURNAL OF GENE MEDICINE, 2019, 21 (07):
[2] CRISPR/Cas9 for genome editing: progress, implications and challenges
Zhang, Feng
Wen, Yan
Guo, Xiong
HUMAN MOLECULAR GENETICS, 2014, 23 : R40 - R46
[3] CRISPR/Cas9 gene editing for genodermatoses: progress and perspectives
Naso, Gaetano
Petrova, Anastasia
EMERGING TOPICS IN LIFE SCIENCES, 2019, 3 (03) : 313 - 326
[4] CRISPR/CAS9 GENE EDITING
不详
CHEMICAL & ENGINEERING NEWS, 2015, : 26 - 27
[5] Delivery methods for CRISPR/Cas9 gene editing in crustaceans
Xu, Sen
Pham, Thinh
Neupane, Swatantra
MARINE LIFE SCIENCE & TECHNOLOGY, 2020, 2 (01) : 1 - 5
[6] Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9
LaFountaine, Justin S.
Fathe, Kristin
Smyth, Hugh D. C.
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 494 (01) : 180 - 194
[7] Delivery methods for CRISPR/Cas9 gene editing in crustaceans
Sen Xu
Thinh Phu Pham
Swatantra Neupane
Marine Life Science & Technology, 2020, 2 : 1 - 5
[8] Therapeutic gene editing in haematological disorders with CRISPR/Cas9
Jensen, Trine I.
Axelgaard, Esben
Bak, Rasmus O.
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (05) : 821 - 835
[9] Therapeutic potential of CRISPR/Cas9 mediated in vivo gene editing for primary hyperoxaluria
Zabaleta, N.
Barberia, M.
Zapata-Linares, N.
Rodriguez, S.
Olaguee, C.
Vales, A.
Abizanda, G.
Iglesias, E.
Salido, E.
Prosper, F.
Gonzalez-Aseguinolaza, G.
Rodriguez-Madoz, J. R.
HUMAN GENE THERAPY, 2016, 27 (11) : A139 - A140
[10] Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells
Malihe Lotfi
Dorsa Morshedi Rad
Samaneh Sharif Mashhadi
Atefeh Ashouri
Majid Mojarrad
Sina Mozaffari-Jovin
Shima Farrokhi
Maryam Hashemi
Marzieh Lotfi
Majid Ebrahimi Warkiani
Mohammad Reza Abbaszadegan
Stem Cell Reviews and Reports, 2023, 19 : 2576 - 2596

← 1 2 3 4 5 →